Contact us
Observe Medical ASA
Dronning Eufemias gate 16
0191 Oslo, Norway
info@observemedical.com
© All Rights Reserved
Observe Medical ASA 2022
Observe Medical ASA 2022
Read More
Read More
Oslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important
Observe Medical ASA invites you to a presentation of the fourth quarter and full year 2019 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, February 25th. Observe Medical ASA invites you to a presentation of the
Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option,
25 February – Presentation of 4. quarter 2019 17 April – Publication of Annual report 2019 12 May – Presentation of 1. quarter 2020 3 June – General meeting 18 August – Publication of 2. quarter / 1. half year
Navamedic ASA, 1 November 2019: Reference is made to Navamedic ASA’s (“NAVA”) and Observe Medical ASA’s (“Observe Medical”) stock exchange announcements dated 30 October 2019 and 31 October 2019, regarding Oslo Børs’ approval of Observe Medical’s application for listing of
Observe Medical ASA
Dronning Eufemias gate 16
0191 Oslo, Norway
info@observemedical.com